ARGUS INVESTORS' COUNSEL, INC.

Position in BSX — Boston Scientific Corp

CIK 7195 NEW YORK, NY

Position in BSX

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$1,613,428

-$939,282 QoQ

Shares Held

25,712

-4.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.52%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 12% Shared 0% None 88%

Healthcare · as of Jun 30, 2026

ARGUS INVESTORS' COUNSEL, INC. holds $1,675,570 across 3 Medical Devices names.

#	Ticker	Company	Shares	Value (USD)
1	DXCM	Dexcom Inc	17,876	$1,203,948
2	ABT	Abbott Laboratories	2,623	$238,011
3	SYK	Stryker Corp	742	$233,611

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,613,428	25,712	-4.0%	Shares	Sole	2026-04-28
2025-12-31	$2,552,710	26,772	-0.1%	Shares	Sole	2026-01-22
2025-09-30	$2,615,995	26,795	-0.3%	Shares	Sole	2025-10-28
2025-06-30	$2,885,354	26,863	+1.6%	Shares	Sole	2025-07-17
2025-03-31	$2,668,074	26,448	+0.4%	Shares	Sole	2025-04-16
2024-12-31	$2,353,760	26,352	-1.7%	Shares	Sole	2025-01-27
2024-09-30	$2,245,421	26,795	—	Shares	Sole	2024-10-21
No filing history on record for this holder in this stock.